Industry News
Research scholarships to help the sugarcane industry
Sugar Research Australia (SRA) is calling for applications for research funding and postgraduate scholarships that will help build the profitability, productivity and sustainability of the Australian sugarcane industry. [ + ]
UCF researchers reducing the drug development process
Researchers at the University of Central Florida (UCF) have led a breakthrough in reducing the drug development process, which currently takes at least a decade and more than US$1 billion to complete. [ + ]
Ancient Roman glass inspires nanoparticle research
Scientists at the University of Adelaide's Institute for Photonics and Advanced Sensing (IPAS) have been inspired in their research by a 1700-year-old Roman glass cup. [ + ]
How early embryos change shape
Researchers at EMBL Australia, based at the Australian Regenerative Medicine Institute at Monash University, have found a new mechanism controlling the process of how embryos change shape. [ + ]
New medal for women in science
The Australian Academy of Science has announced a new medal to honour women in science. [ + ]
Merck Biopharm osteoarthritis co-research agreement
Biopharm and Merck Serono have entered a joint discovery project focusing on a potential pro-anabolic osteoarthritis modifying drug based on a growth factor derived from the Biopharm growth factor platform technology. [ + ]
Nancy Millis Medal to honour women in science
The Australian Academy of Science has created a new award - the Nancy Millis Medal - which recognises outstanding research and leadership by early- to mid-career Australian women who have established independent research in the natural sciences. [ + ]
Questacon celebrates 25th anniversary
Saturday 23 November marks the 25th anniversary of Questacon - The National Science and Technology Centre. The multiaward-winning tourist attraction features eight galleries with over 200 interactive exhibits. [ + ]
ResMed wins temporary German injunctions in patent suits
A German court has ordered a Taiwanese and a Chinese medical device manufacturer to stop selling some devices alleged to infringe ResMed (ASX:RMD) patents without a further court order. [ + ]
Biotron gets ethics nod for HCV trial
Biotron (ASX:BIT) has received ethics approval for a three-month trial of the new capsule formulation of antiviral drug BIT225 in hepatitis C patients. [ + ]
SYNthesis med chem names European chief
SYNthesis med chem has built on the launch of its new facility in the UK with the appointment of a new head of European operations. [ + ]
Langerhan cells reveal differences
Despite appearing identical, Langerhan cells of the skin come in two genetically distinct types. [ + ]
TGA streamlines adverse event reporting
AusBiotech has welcomed the TGA's announcement that it has introduced a streamlined way for sponsors to submit adverse event reports for medicines and vaccines, to ease the administrative burden of the 7000-8000 annual reports. [ + ]
Mesoblast MPCs improve function in heart failure
During a recent trial, heart failure patients on assisted circular support demonstrated improved cardiac function when injected with Mesoblast (ASX:MSB) MPCs at time of LVAD implantation. [ + ]
Supporting Indigenous health and wellbeing
A philanthropic donation of $10 million for Indigenous health has been gifted to the University of Western Australia. [ + ]
